PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for April 28, 2008 Subscribe to this News Feed    
 

VitalCare Signs LOI For Diabetes Treatment Center In Utah

Center Will Provide iCAT Therapy for Type 1 and Type 2 Diabetics

CARSON CITY, Nev. (Business Wire EON/PRWEB ) April 28, 2008 -- VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI) a Nevada corporation, today announced they have signed a letter of intent to establish a joint-venture relationship with South Valley Inpulse Center, LLC, an existing Diabetes Treatment Center in Draper, Utah. The center will be administering the FDA approved iCAT treatment for Type 1 and Type 2 diabetes patients.

Jimmy McDougald, CEO, stated, This is the part of our Mid-West launch and we are excited to be offering iCAT therapy to diabetics in this region. We see this as an opportunity to work with an established team of healthcare professionals.

News Image Diana Harrison, Managing Partner of South Valley Inpulse Center, said, We are excited about this opportunity to work with VitalCare to expand our program, giving more people access to this treatment and the hope in a better quality of life.

About VitalCare Diabetes Treatment Centers, Inc.

VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing Cutting Edge medical devices and healthcare services direct to consumers, focusing on an emerging FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as Intracellular Activation Therapy (iCAT).

Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward- looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCares filings with the Securities and Exchange Commission.

See the original story at: http://eon.businesswire.com/releases/center/diabetes/prweb897574.htm

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1Db3VwLUNvdXAtSG9yci1GYWx1LVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION

VitalCare Diabetes Treatment Centers, Inc.
Investor Relations:
Jimmy McDougald, 1-909-981-9192
Fax: 1-909-931-1780
Toll Free: 1-877-NO-DIABETES
info@vitalcaretechnology.com

ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move